Health Canada’s regulatory response to COVID-19: Access to health products

As part of the government's broad response to the pandemic, Health Canada introduced innovative and agile regulatory measures. These measures expedite the regulatory review of COVID-19 health products without compromising safety, efficacy and quality standards.

Données et ressources

Info additionnelle

Champ Valeur
Dernière modification avril 17, 2026, 21:45 (TU)
Créé le avril 17, 2026, 21:45 (TU)
criticality_level []
geographic_scope []
open_canada_collection publication
open_canada_date_published 2021-03-31 00:00:00
open_canada_keywords {"fr": ["Réponse à la pandémie", "réponse réglementaire au COVID-19", "mesures réglementaires", "accès aux produits de santé", "mesures accélèrent l'examen réglementaire", "normes de sécurité", "d'efficacité et de qualité"], "en": ["Response to pandemic", "Regulatory response to COVID-19", "regulatory measures", "access to health products", "measures expedite the regulatory review", "safety", "efficacy and quality standards"]}
open_canada_subject ["health_and_safety"]
sensitivity_level unrestricted
title_fr Réponse de Santé Canada en matière de réglementation face à la COVID 19 : Accès aux produits de santé
update_frequency as_needed